BOULDER, Colo., Oct. 29, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, November 4, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.
Date: | Tuesday, November 4, 2014 |
Time: | 9:00 a.m. Eastern Time |
Toll-Free: | (800) 708-4540 |
Toll: | (847) 619-6397 |
Pass Code: | 38177000 |
Webcast, including Replay and Conference Call Slides: | |
http://www.media-server.com/m/acs/835a9ca60ab7df8747dc3aa3ad1d878b | |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 studies are in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
(303) 386-1193 | |
SOURCE Array BioPharma
Help employers find you! Check out all the jobs and post your resume.
